Health and Human Services Secretary Robert F. Kennedy Jr. remains in his role despite ongoing controversies, including the recent resignation of his chief spokesperson on May 13 over e-cigarette flavor policy disputes and the ouster of FDA Commissioner Marty Makary amid public health tensions. RFK Jr. actively defended HHS budget cuts and priorities in April congressional hearings before House and Senate committees, signaling sustained leadership backed by President Trump, as seen in their joint hantavirus response. Calls for his resignation from HHS staff and criticism of agency leadership vacuums persist, but no official withdrawal, firing, or replacement announcements have emerged, anchoring trader consensus at 68.5% for him staying through December 31 amid a competitive political environment.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · Оновлено$18,792 Обс.
$18,792 Обс.
$18,792 Обс.
$18,792 Обс.
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Ринок відкрито: Mar 19, 2026, 2:02 PM ET
Resolver
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...Health and Human Services Secretary Robert F. Kennedy Jr. remains in his role despite ongoing controversies, including the recent resignation of his chief spokesperson on May 13 over e-cigarette flavor policy disputes and the ouster of FDA Commissioner Marty Makary amid public health tensions. RFK Jr. actively defended HHS budget cuts and priorities in April congressional hearings before House and Senate committees, signaling sustained leadership backed by President Trump, as seen in their joint hantavirus response. Calls for his resignation from HHS staff and criticism of agency leadership vacuums persist, but no official withdrawal, firing, or replacement announcements have emerged, anchoring trader consensus at 68.5% for him staying through December 31 amid a competitive political environment.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · Оновлено
Обережно з зовнішніми посиланнями.
Обережно з зовнішніми посиланнями.
Часті запитання